Lista de obras -

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

artículo científico publicado en 2011

Abstract 3975: Ovarian cancer cells release arginase-1-containing exosomes to suppress antitumor immune response

Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

artículo científico publicado en 2016

Characterization of Extracellular Vesicles from Bronchoalveolar Lavage Fluid and Plasma of Patients with Lung Lesions Using Fluorescence Nanoparticle Tracking Analysis

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin

artículo científico publicado en 2009

Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response

scientific article published on 20 August 2019

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

artículo científico publicado en 2009

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death

artículo científico publicado en 2009

Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia

artículo científico publicado en 2009

Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.

artículo científico publicado en 2010

Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).

scientific article published on 12 March 2010

Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.

artículo científico publicado en 2019

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.

artículo científico publicado en 2009

The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.

artículo científico publicado en 2012

The potential role of tumor-derived exosomes in diagnosis, prognosis and response to therapy in cancer

artículo científico publicado en 2020

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

artículo científico publicado en 2009

Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression

artículo científico publicado en 2009

Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

artículo científico publicado en 2010

Up-regulation of natural killer (NK) cell activating receptors and increase in NK mediated cytotoxicity using interleukin-15 in patients with newly diagnosed acute myeloid leukemia (AML)

Lista de obras de

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Abstract 3975: Ovarian cancer cells release arginase-1-containing exosomes to suppress antitumor immune response

Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

Characterization of Extracellular Vesicles from Bronchoalveolar Lavage Fluid and Plasma of Patients with Lung Lesions Using Fluorescence Nanoparticle Tracking Analysis

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin

Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death

Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia

Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.

Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).

Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.

The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC.

The potential role of tumor-derived exosomes in diagnosis, prognosis and response to therapy in cancer

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression

Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

Up-regulation of natural killer (NK) cell activating receptors and increase in NK mediated cytotoxicity using interleukin-15 in patients with newly diagnosed acute myeloid leukemia (AML)